Khalifa Muhammad, Gingold-Belfer Rachel, Issa Nidal
Department of Surgery, Rabin Medical Center-Hasharon Hospital, Faculty of Medicine, Tel Aviv University, Petach Tikva 49100, Israel.
Department of Gastroenterology, Rabin Medical Center-Hasharon Hospital, Tel Aviv University, Petach Tikva 49100, Israel.
J Clin Med. 2024 Feb 29;13(5):1419. doi: 10.3390/jcm13051419.
: Local excision by transanal endoscopic microsurgery (TEM) is considered an acceptable treatment for rectal adenomas with high-grade dysplasia (HGD). This study aims to assess the likelihood of harboring an invasive carcinoma in preoperatively diagnosed HGD polyps and evaluate the risk factors for tumor recurrence in patients with final HGD pathology. : Data from patients who underwent TEM procedures for adenomatous lesions with HGD from 2005 to 2018 at the Rabin Medical Center, Hasharon Hospital, were analyzed. Collected data included patient demographics, preoperative workup, tumor characteristics and postoperative results. Follow-up data including recurrence assessment and further treatments were reviewed. The analysis included two subsets: preoperative pathology of HGD (sub-group 1) and postoperative final pathology of HGD (sub-group 2) patients. : Forty-five patients were included in the study. Thirty-six patients had a preoperative diagnosis of HGD, with thirteen (36%) showing postoperative invasive carcinoma. Thirty-two patients had a final pathology of HGD, and three (9.4%) experienced tumor recurrence. Large tumor size (>5 cm) was significantly associated with recurrence ( = 0.03). : HGD rectal polyps are associated with a significant risk of invasive cancer. Tumor size was a significant factor in predicting tumor recurrence in patients with postoperative HGD pathology. The TEM procedure is an effective first-line treatment for such lesions.
经肛门内镜显微手术(TEM)进行局部切除被认为是治疗高级别异型增生(HGD)直肠腺瘤的一种可接受的方法。本研究旨在评估术前诊断为HGD的息肉中存在浸润性癌的可能性,并评估最终病理诊断为HGD的患者肿瘤复发的危险因素。:对2005年至2018年在哈沙龙医院拉宾医疗中心接受TEM手术治疗HGD腺瘤性病变的患者数据进行分析。收集的数据包括患者人口统计学信息、术前检查、肿瘤特征和术后结果。回顾随访数据,包括复发评估和进一步治疗情况。分析包括两个亚组:HGD术前病理(亚组1)和HGD术后最终病理(亚组2)患者。:45例患者纳入研究。36例患者术前诊断为HGD,其中13例(36%)术后显示浸润性癌。32例患者最终病理诊断为HGD,3例(9.4%)出现肿瘤复发。肿瘤大尺寸(>5 cm)与复发显著相关(P = 0.03)。:HGD直肠息肉与浸润性癌的显著风险相关。肿瘤大小是预测术后HGD病理患者肿瘤复发的一个重要因素。TEM手术是治疗此类病变的一种有效的一线治疗方法。